Inhibition by etazolate (SQ 20009) and cartazolate (SQ 65396) of adenosine-stimulated [3H]cAMP formation in [2-3H]adenine-prelabeled vesicles prepared from guinea pig cerebral cortex

This publication has 19 references indexed in Scilit:

• Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nuleosides, nucleotides, and pharmacological phosphodiesterase inhibitors
  Biochemical Pharmacology, 1979
• Studies on the inhibition of phosphodiesterase-catalyzed cyclic AMP and cyclic GMP breakdown and relaxation of canine tracheal smooth muscle
  Biochemical Pharmacology, 1978
• Phosphodiesterase in the liver fluke, fasciola hepatica
  Biochemical Pharmacology, 1977
• Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3′,5′-monophosphate phosphodiesterase
  Cellular and Molecular Life Sciences, 1975
• Effect of glucagon, dibutyryl adenosine 3′,5′-cyclic monophosphate and phosphodiesterase inhibitors on rat liver phosphorylase activity and adenosine 3′,5′-cyclic monophosphate levels
  Biochemical Pharmacology, 1974
• Inhibition of 3′,5′-nucleotide phosphodiesterase in guinea pig cerebral cortical slices
  Archives of Biochemistry and Biophysics, 1974
• Characterization of cyclic 3', 5'-nucleotide phosphodiesterase activity in an islet cell tumor of the syrian hamster
  Molecular and Cellular Endocrinology, 1974
• 1-ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)—a potent new inhibitor of cyclic 3′,5′-nucleotide phosphodiesterases
  Biochemical Pharmacology, 1972
• Cyclic Adenosine Monophosphate Phosphodiesterase in Brain: Effect on Anxiety
  Science, 1972
• Cyclic AMP and Anxiety
  Psychosomatics, 1972